Campylobacter Infection in Children in Malawi Is Common and Is Frequently Associated with Enteric Virus Co-Infections

Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom.
PLoS ONE (Impact Factor: 3.53). 03/2013; 8(3):e59663. DOI: 10.1371/journal.pone.0059663
Source: PubMed

ABSTRACT Campylobacter species are the most common cause of bacterial gastroenteritis in the developed world. However, comparatively few studies have determined the epidemiological features of campylobacteriosis in resource-poor settings.
A total of 1,941 faecal specimens collected from symptomatic (diarrhoeic) children and 507 specimens from asymptomatic (non-diarrhoeic) children hospitalised in Blantyre, Malawi, between 1997 and 2007, and previously tested for the presence of rotavirus and norovirus, was analysed for C. jejuni and C. coli using a real time PCR assay.
Campylobacter species were detected in 415/1,941 (21%) of diarrhoeic children, with C. jejuni accounting for 85% of all cases. The median age of children with Campylobacter infection was 11 months (range 0.1-55 months), and was significantly higher than that for children with rotavirus and norovirus (6 months and 7 months respectively; P<0.001). Co-infection with either rotavirus or norovirus was noted in 41% of all cases in the diarrhoeic group. In contrast, the detection rate of Campylobacter in the non-diarrhoeic group was 14%, with viral co-infection identified in 16% of children with Campylobacter. There was no association between Campylobacter detection rate and season over the 10 year period.
Using molecular detection methodology in hospitalised Malawian children, we have demonstrated a high prevalence of Campylobacter infection, with frequent viral co-infection. The burden of Campylobacter infection in young African children may be greater than previously recognised.


Available from: Martin C J Maiden, Jun 12, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: SETTING: Atoifi Adventist Hospital (AAH), Solomon Islands, the only hospital in the East Kwaio region. OBJECTIVE: To use routine surveillance data to assess the trends in malaria from 2008 to 2013. DESIGN: Descriptive study of records from (1) AAH laboratory malaria records; (2) admissions to AAH for malaria; and (3) malaria treatments from outpatient records. RESULTS: AAH examined 35 608 blood films and diagnosed malaria in 4443 samples comprised of 2667 Plasmodium falciparum (Pf) and 1776 Plasmodium vivax (Pv). Between 2008 and 2013 the total number of malaria cases detected annually decreased by 86.5%, Pf by 96.7% and Pv by 65.3%. The ratio of Pf to Pv reversed in 2010 from 2.06 in 2008 to 0.19 in 2013. For 2013, Pf showed a seasonal pattern with no cases diagnosed in four months. From 2008 to 2013 admissions in AAH for malaria declined by 90.8%, and malaria mortality fell from 54 per 100 000 to zero. The annual parasite index (API) for 2008 and 2013 was 195 and 24, respectively. Village API has identified a group of villages with higher malaria incidence rates. CONCLUSION: The decline in malaria cases in the AAH catchment area has been spectacular, particularly for Pf. This was supported by three sources of hospital surveillance data (laboratory, admissions and treatment records). The decline was associated with the use of artemisinin-based combined therapy and improved vertical social capital between the AAH and the local communities. Calculating village-specific API has highlighted which villages need to be targeted by the AAH malaria control team.
    09/2014; 5:30-9. DOI:10.5365/wpsar.2014.5.3.002
  • [Show abstract] [Hide abstract]
    ABSTRACT: Data on campylobacteriosis in developed countries are well documented; in contrast, few studies on campylobacteriosis have been conducted in developing countries. This study was undertaken to test for Campylobacter in human faecal samples sent to the two major pathology laboratories in Fiji. A total of 408 diarrhoeal faecal samples were collected from the two major hospital pathology laboratories in Central Fiji (Suva) and Western Fiji (Lautoka) between December 2012 and February 2013 and from June to July 2013. Samples were analysed for the presence of Campylobacter using polymerase chain reaction (PCR) based methods. Campylobacter was detected in 241/408 (59.1%) of samples tested using PCR. Samples from children aged less than five accounted for 21.6% of positive cases. Campylobacter was detected in 59.1% of diarrhoeal samples collected from the two main laboratories in Fiji. A high proportion of children under five years with Campylobacter has been reported in other countries and could be due to parents being more likely to seek medical attention. Further studies are required to confirm the species of Campylobacter that are predominantly associated with gastroenteritis in Fiji.
    10/2014; 5(4):30-33. DOI:10.5365/WPSAR.2014.5.2.007
  • [Show abstract] [Hide abstract]
    ABSTRACT: Campylobacter is a common bacterial enteropathogen that can be detected in stool by culture, enzyme immunoassay, or PCR. We compared culture for C. jejuni/coli, EIA (ProSpecT), and duplex PCR to distinguish Campylobacter jejuni/coli and non-jejuni/coli Campylobacter on 432 diarrheal and matched control stool samples from infants in a multisite longitudinal study of enteric infections in Tanzania, Bangladesh, and Peru. Sensitivity and specificity of culture was 8.5% and 97.6% respectively compared with EIA and 8.7% and 98.0% compared with PCR for C. jejuni/coli. Most (71.6%) EIA-positive samples were positive by PCR for C. jejuni/coli but 27.6% were positive for non-jejuni/coli Campylobacter species. Sequencing of 16S rRNA from 53 of these non-jejuni/coli Campylobacter samples most closely matched C. hyointestinalis subsp. lawsonii (56%), C. troglodytis (33%), C. upsaliensis (7.7%) and C. jejuni/coli (2.6%). Campylobacter negative stool spiked with each of the above Campylobacter species revealed reactivity with EIA. PCR detection of Campylobacter species was strongly associated with diarrhea in Peru (OR 3.66, P < .001) but not in Tanzania (OR 1.56, P = .24) or Bangladesh (OR 1.13, P = .75). According to PCR, Campylobacter jejuni/coli infections represented less than half of all infections with Campylobacter species. In sum, in infants in developing country settings the ProSpecT EIA and PCR for Campylobacter reveal extremely high rates of positivity. We would propose the use of PCR because it retains high sensitivity, can ascertain burden, and can distinguish between Campylobacter infections at the species level.
    Journal of clinical microbiology 01/2014; 52(4). DOI:10.1128/JCM.02935-13 · 4.23 Impact Factor